Abstract
Three-dimensional radiomic analysis of digital breast tomosynthesis outperformed two-dimensional measures in breast cancer risk assessment.
Funding Information
  • National Institutes of Health (R01CA161749)
  • National Cancer Institute (R01CA161749)